Definitely interested trading for first time in a long while.
The tech can't be too bad given calimmune proceeded into next stage of their trial with something like 4 x 24 patient cohorts, and tt-034 can't be going too bad either given the bremner lab advertised for an experienced RA only last week.
Definitely interested trading for first time in a long while....
Add to My Watchlist
What is My Watchlist?